Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Insights into Dynamic Network States Using Metabolomic Data.

Mostolizadeh R, Dräger A, Jamshidi N.

Methods Mol Biol. 2019;1978:243-258. doi: 10.1007/978-1-4939-9236-2_15.

PMID:
31119667
2.

Receptor-based Surrogate Subtypes and Discrepancies with Breast Cancer Intrinsic Subtypes: Implications for Image Biomarker Development.

Jamshidi N, Yamamoto S, Gornbein J, Kuo MD.

Radiology. 2018 Oct;289(1):210-217. doi: 10.1148/radiol.2018171118. Epub 2018 Jul 24.

PMID:
30040052
3.

Genomic Adequacy from Solid Tumor Core Needle Biopsies of ex Vivo Tissue and in Vivo Lung Masses: Prospective Study.

Jamshidi N, Huang D, Abtin FG, Loh CT, Kee ST, Suh RD, Yamamoto S, Das K, Dry S, Binder S, Enzmann DR, Kuo MD.

Radiology. 2017 Mar;282(3):903-912. doi: 10.1148/radiol.2016132230. Epub 2016 Oct 18.

PMID:
27755912
4.

Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition.

Du L, Yamamoto S, Burnette BL, Huang D, Gao K, Jamshidi N, Kuo MD.

Cancer Med. 2016 Aug;5(8):1962-72. doi: 10.1002/cam4.719. Epub 2016 Jun 18.

5.

Radiogenomic Analysis Demonstrates Associations between (18)F-Fluoro-2-Deoxyglucose PET, Prognosis, and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.

Yamamoto S, Huang D, Du L, Korn RL, Jamshidi N, Burnette BL, Kuo MD.

Radiology. 2016 Jul;280(1):261-70. doi: 10.1148/radiol.2016160259. Epub 2016 Apr 15.

PMID:
27082783
6.

The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial.

Jamshidi N, Jonasch E, Zapala M, Korn RL, Brooks JD, Ljungberg B, Kuo MD.

Eur Radiol. 2016 Aug;26(8):2798-807. doi: 10.1007/s00330-015-4082-8. Epub 2015 Nov 11.

PMID:
26560727
7.

The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma.

Jamshidi N, Jonasch E, Zapala M, Korn RL, Aganovic L, Zhao H, Tumkur Sitaram R, Tibshirani RJ, Banerjee S, Brooks JD, Ljungberg B, Kuo MD.

Radiology. 2015 Oct;277(1):114-23. doi: 10.1148/radiol.2015150800. Epub 2015 Aug 19.

PMID:
26402495
8.

Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis.

Yamamoto S, Han W, Kim Y, Du L, Jamshidi N, Huang D, Kim JH, Kuo MD.

Radiology. 2015 May;275(2):384-92. doi: 10.1148/radiol.15142698. Epub 2015 Feb 26.

PMID:
25734557
9.

Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation.

Jamshidi N, Diehn M, Bredel M, Kuo MD.

Radiology. 2014 Jan;270(1):1-2. doi: 10.1148/radiol.13130078. Epub 2013 Oct 28.

10.

Parameter optimization for quantitative signal-concentration mapping using spoiled gradient echo MRI.

Hathout G, Jamshidi N.

Radiol Res Pract. 2012;2012:815729. doi: 10.1155/2012/815729. Epub 2012 Nov 5.

Supplemental Content

Loading ...
Support Center